Japan Calcium Tablet and Oral Liquid Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Calcium Tablets and Calcium Oral Liquid), By Application (Bone Health, Osteoporosis, and Cardiovascular Health), and Japan Calcium Tablet and Oral Liquid Market Insights, Industry Trend, Forecasts to 2033
Industry: HealthcareJapan Calcium Tablet and Oral Liquid Market Insights Forecasts to 2033
- The Market is Growing at a CAGR of 5.27% from 2023 to 2033
- The Japan Calcium Tablet and Oral Liquid Market Size is Expected to hold a significant share by 2033
Get more details on this report -
The Japan Calcium Tablet and Oral Liquid Market is Anticipated to hold a significant share by 2033, growing at a CAGR of 5.27% from 2023 to 2033.
Market Overview
The manufacturing, distribution, and consumption of calcium-based supplements in tablet and liquid form are the main focuses of the Japan calcium tablet and oral liquid market. Growing awareness of the value of bone health for people of all ages is another major factor propelling the Japanese market for calcium tablets and oral liquids. In order to address health issues like osteoporosis, healthcare groups and the Japanese government have launched campaigns and educational initiatives that highlight the importance of consuming enough calcium, particularly for women and children. Calcium supplements, which come in a variety of formats like tablets and oral liquids, are becoming more and more popular in Japan as a result of this growing knowledge. Further supporting the market's expansion in Japan is the growing trend of self-medication and preventative healthcare practices, which are pushing people to proactively include calcium supplements in their daily routines.
Report Coverage
This research report categorizes the market for the Japan calcium tablet and oral liquid market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan calcium tablet and oral liquid market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan calcium tablet and oral liquid market.
Japan Calcium Tablet and Oral Liquid Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2023 |
Forecast Period: | 2023 – 2033 |
Forecast Period CAGR 2023 – 2033 : | 5.27% |
Historical Data for: | 2019-2022 |
No. of Pages: | 258 |
Tables, Charts & Figures: | 128 |
Segments covered: | By Product Type, By Application |
Companies covered:: | Eisai Co., Ltd. Morinaga Milk Industry Co., Ltd. UNIMAT RIKEN Co., Ltd. ORIHIRO Co., Ltd. Asahi Group Holdings, Ltd. Otsuka Pharmaceutical Co., Ltd. DHC Corporation Others |
Pitfalls & Challenges: | COVID-19 Empact,Challenges, Future, Growth, & Analysis |
Get more details on this report -
Driving Factors
The aging population in Japan is one of the main drivers of the market for calcium tablets and oral liquids. In Japan, the need for calcium supplements is increasing as people age because their bones weaken and become more vulnerable to diseases like osteoporosis. The need for these items to preserve bone health and avoid fractures is being greatly increased by Japan's demographic trend of an aging population. The market's expansion is also being aided by the growing incidence of lifestyle-related illnesses in Japan, such as hypertension and cardiovascular problems, which can be treated with calcium supplements. This emphasizes how crucial calcium supplements are to meeting the unique health requirements of the Japanese people. Additionally, more than 15 million people in Japan suffer from osteoporosis, according to population-based estimates, and hospital care for fractures costs billions of dollars per year. The market for calcium tablets and oral liquids in Japan is expanding because to the rising incidence of osteoporosis, increased awareness of bone health, and the significance of calcium intake.
Restraining Factors
The market is also confronted with a number of risks and difficulties that may hinder its expansion. The possibility of adverse effects and contraindications linked to high calcium intake is one important limitation. Kidney stones and cardiovascular problems are among the negative health effects that might result from taking too many calcium supplements.
Market Segmentation
The Japan calcium tablet and oral liquid market share is classified into product type and application.
- The calcium tablets segment is expected to hold a significant market share through the forecast period.
The Japan calcium tablet and oral liquid market is segmented by product type into calcium tablets and calcium oral liquid. Among these, the calcium tablets segment is expected to hold a significant market share through the forecast period. This is because of their accurate dosing and ease of use; calcium tablets are well-liked by people of all ages. They are readily available through a variety of distribution channels, such as pharmacies and internet retailers, and are frequently prescribed by medical practitioners.
- The bone health segment is expected to hold a significant market share through the forecast period.
The Japan calcium tablet and oral liquid market is segmented by application into bone health, osteoporosis, and cardiovascular health. Among these, the bone health segment is expected to hold a significant market share through the forecast period. One of the main causes is the rising prevalence of osteoporosis, especially in postmenopausal women. It is commonly advised to take calcium supplements in order to preserve bone density and avoid fractures. Demand is also being increased by the increased awareness of bone health throughout all age groups.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Japan calcium tablet and oral liquid market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- Eisai Co., Ltd.
- Morinaga Milk Industry Co., Ltd.
- UNIMAT RIKEN Co., Ltd.
- ORIHIRO Co., Ltd.
- Asahi Group Holdings, Ltd.
- Otsuka Pharmaceutical Co., Ltd.
- DHC Corporation
- Others
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at Japan, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Japan Calcium Tablet and Oral Liquid Market based on the below-mentioned segments:
Japan Calcium Tablet and Oral Liquid Market, By Product Type
- Calcium Tablets
- Calcium Oral Liquid
Japan Calcium Tablet and Oral Liquid Market, By Application
- Bone Health
- Osteoporosis
- Cardiovascular Health
Need help to buy this report?